Meanwhile, MK-1167 is a peripheral adrenergic modulator (PAM) that aims to correct a neurotransmitter imbalance in the brain. This could…
Browsing: Merck
Merck & Co.’s recent acquisition of Verona Pharma for $10 billion marks a significant milestone for the company, as it…
Manufacturing investments have become a focal point in the pharmaceutical industry in recent years, with companies like Eli Lilly and…
Merck & Co.’s Keytruda has been a dominant force in the world of cancer treatment for over a decade, securing…
